Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 16:7:351.
doi: 10.3332/ecancer.2013.351. eCollection 2013.

Measuring patient-reported outcomes in advanced gastric cancer

Jianming Xu  1 , Tr Jeffry Evans, Cheryl Coon, Kati Copley-Merriman, Yun Su
Affiliations

Measuring patient-reported outcomes in advanced gastric cancer

Jianming Xu et al. Ecancermedicalscience. .

Abstract

Background: Gastric cancer (GC), one of the most common cancers in the world, is often diagnosed at an advanced stage and associated with a poor prognosis. Quality of life and patient-reported outcomes (PROs) are important considerations when treating GC patients. The aim of this study was to identify existing PRO instruments that would be appropriate for use in GC trials.

Methods: Data were obtained from a systematic literature review and interviews with clinical experts. A literature search was conducted using OVID (EMBASE and MEDLINE) and yielded 1,008 abstracts; 92 assessed PROs in an advanced GC.

Results: Key symptoms and functional impacts identified through the literature and expert input included abdominal pain or pain at the site of distant metastases, dysphagia and other symptoms related to eating, and digestive symptoms. The liver and lungs were the most frequent locations of metastases, leading to dyspnea, abdominal fullness, and jaundice. Symptoms related to changes in bowel habits appeared to be more frequent and pronounced in Asian patients, possibly due to the higher prevalence of GC in the body of the stomach in this population. The five most commonly used PRO instruments were identified, but their validity in advanced-stage GC patients remains unclear.

Conclusions: The symptoms and functional impacts identified here should be confirmed with robust input from advanced-stage GC patients. Optimal measurement of PROs in GC should account for patient burden and possible differences between Asian and non-Asian patients.

Keywords: digestive signs; gastric cancer; outcome measures; patient outcome assessment; symptoms.

PubMed Disclaimer

References

    1. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1–9. doi: 10.1016/S08954356(02)00534-6. - DOI - PubMed
    1. Blot WJ, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–9. doi: 10.1001/jama.1991.03460100089030. - DOI - PubMed
    1. National Comprehensive Cancer Network. 2012. [August 23 2012]. Clinical practice guidelines in oncology: gastric cancer Version 2 Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site(registration required)
    1. International Agency for Research on Cancer. 2008. [March 22 2012]. Cancer fact sheet: stomach cancer incidence, mortality and prevalence worldwide in 2008. http://globocan.iarc.fr/factsheet.asp.
    1. Bowrey DJ, et al. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc. 2006;20(11):1725–8. doi: 10.1007/s00464-005-0679-3. - DOI - PubMed

LinkOut - more resources